{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:01:35Z","timestamp":1782961295363,"version":"3.54.5"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-genitourinary-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.clgc.2024.102280","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T17:22:19Z","timestamp":1733246539000},"page":"102280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Comprehensive Genetic Profile of Chinese Muscle-Invasive Bladder Cancer Cohort"],"prefix":"10.1016","volume":"23","author":[{"given":"Sujun","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhannan","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqing","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2696-5279","authenticated-orcid":false,"given":"Nianzeng","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.clgc.2024.102280_bib0001","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"10.1016\/j.clgc.2024.102280_bib0002","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.clgc.2024.102280_bib0003","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3322\/caac.21338","article-title":"Cancer statistics in China","volume":"66","author":"Chen","year":"2015","journal-title":"CA Cancer J Clin 2016"},{"key":"10.1016\/j.clgc.2024.102280_bib0004","article-title":"Comparative analysis of differentially mutated genes in non-muscle and muscle-invasive bladder cancer in the chinese population by whole exome sequencing","volume":"13","author":"Wang","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/j.clgc.2024.102280_bib0005","doi-asserted-by":"crossref","DOI":"10.1177\/11769343211049270","article-title":"Exploration of Prognostic biomarkers of muscle-invasive bladder cancer (MIBC) by bioinformatics","volume":"17","author":"Xu","year":"2021","journal-title":"Evol Bioinform Online"},{"issue":"5","key":"10.1016\/j.clgc.2024.102280_bib0006","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3322\/caac.21631","article-title":"Treatment of muscle-invasive and advanced bladder cancer in 2020","volume":"70","author":"Patel","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.clgc.2024.102280_bib0007","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.eururo.2016.06.020","article-title":"Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer","volume":"71","author":"Alfred Witjes","year":"2017","journal-title":"Eur Urol"},{"issue":"10","key":"10.1016\/j.clgc.2024.102280_bib0008","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/j.mayocp.2017.07.010","article-title":"Management of muscle-invasive urothelial cancer and the emerging role of immunotherapy in advanced urothelial cancer","volume":"92","author":"Giridhar","year":"2017","journal-title":"Mayo Clin Proc"},{"issue":"7492","key":"10.1016\/j.clgc.2024.102280_bib0009","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature12965","article-title":"Comprehensive molecular characterization of urothelial bladder carcinoma","volume":"507","year":"2014","journal-title":"Nature"},{"issue":"7471","key":"10.1016\/j.clgc.2024.102280_bib0010","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature12634","article-title":"Mutational landscape and significance across 12 major cancer types","volume":"502","author":"Kandoth","year":"2013","journal-title":"Nature"},{"issue":"25","key":"10.1016\/j.clgc.2024.102280_bib0011","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1200\/JCO.2012.46.5740","article-title":"Prevalence and co-occurrence of actionable genomic alterations in high-grade bladder cancer","volume":"31","author":"Iyer","year":"2013","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.clgc.2024.102280_bib0012","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.clgc.2024.102280_bib0013","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.cell.2018.07.036","article-title":"Comprehensive molecular characterization of muscle-invasive bladder cancer","volume":"174","author":"Robertson","year":"2018","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.clgc.2024.102280_bib0014","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nrc3817","article-title":"Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity","volume":"15","author":"Knowles","year":"2015","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"10.1016\/j.clgc.2024.102280_bib0015","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.eururo.2017.05.032","article-title":"Next-generation sequencing of nonmuscle invasive bladder cancer reveals potential biomarkers and rational therapeutic targets","volume":"72","author":"Pietzak","year":"2017","journal-title":"Eur Urol"},{"issue":"7457","key":"10.1016\/j.clgc.2024.102280_bib0016","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature12213","article-title":"Mutational heterogeneity in cancer and the search for new cancer-associated genes","volume":"499","author":"Lawrence","year":"2013","journal-title":"Nature"},{"issue":"218","key":"10.1016\/j.clgc.2024.102280_bib0017","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1080\/03008880802291915","article-title":"Molecular alterations associated with bladder cancer initiation and progression","author":"Cordon-Cardo","year":"2008","journal-title":"Scand J Urol Nephrol Suppl"},{"issue":"23","key":"10.1016\/j.clgc.2024.102280_bib0018","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15235649","article-title":"Clonality analysis for the relationship between the pulmonary combined neuroendocrine carcinoma and \"the so-called reported histologic transformation\"","volume":"15","author":"Wang","year":"2023","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.clgc.2024.102280_bib0019","doi-asserted-by":"crossref","first-page":"10575","DOI":"10.1002\/cam4.5795","article-title":"Molecular genetic characteristics of thymic epithelial tumors with distinct histological subtypes","volume":"12","author":"Yang","year":"2023","journal-title":"Cancer Med"},{"issue":"5","key":"10.1016\/j.clgc.2024.102280_bib0020","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: an R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"OMICS"},{"issue":"2","key":"10.1016\/j.clgc.2024.102280_bib0021","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1097\/PAI.0000000000000575","article-title":"Microsatellite instability: a predictive biomarker for cancer immunotherapy","volume":"26","author":"Chang","year":"2018","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"6","key":"10.1016\/j.clgc.2024.102280_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.currproblcancer.2019.03.002","article-title":"Microsatellite instability profiling in Egyptian bladder cancer patients: a pilot study","volume":"43","author":"Zekri","year":"2019","journal-title":"Curr Probl Cancer"},{"issue":"2","key":"10.1016\/j.clgc.2024.102280_bib0023","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10147-016-1068-8","article-title":"Biomarkers for precision medicine in bladder cancer","volume":"22","author":"Kojima","year":"2017","journal-title":"Int J Clin Oncol"},{"issue":"3","key":"10.1016\/j.clgc.2024.102280_bib0024","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","article-title":"Comprehensive molecular characterization of muscle-invasive bladder cancer","volume":"171","author":"Robertson","year":"2017","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.clgc.2024.102280_bib0025","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ccell.2017.08.005","article-title":"Genomic subtypes of non-invasive bladder cancer with distinct metabolic profile and female gender bias in KDM6A mutation frequency","volume":"32","author":"Hurst","year":"2017","journal-title":"Cancer Cell"},{"issue":"17","key":"10.1016\/j.clgc.2024.102280_bib0026","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21176072","article-title":"Mutational landscape and environmental effects in bladder cancer","volume":"21","author":"Hayashi","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.clgc.2024.102280_bib0027","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.eururo.2020.03.049","article-title":"Procarcinogen activation and mutational signatures model the initiation of carcinogenesis in human urothelial tissues in vitro","volume":"78","author":"Baker","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2024.102280_bib0028","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.3389\/fonc.2020.01643","article-title":"Genomic profiling identified ERCC2 E606Q mutation in helicase domain respond to platinum-based neoadjuvant therapy in urothelial bladder cancer","volume":"10","author":"Hirotsu","year":"2020","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.clgc.2024.102280_bib0029","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1186\/s12885-021-08372-9","article-title":"Significance of KDM6A mutation in bladder cancer immune escape","volume":"21","author":"Chen","year":"2021","journal-title":"BMC Cancer"},{"issue":"8","key":"10.1016\/j.clgc.2024.102280_bib0030","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1158\/1078-0432.CCR-18-3147","article-title":"Mutational analysis of 472 urothelial carcinoma across grades and anatomic sites","volume":"25","author":"Nassar","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.clgc.2024.102280_bib0031","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/ng.3557","article-title":"Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors","volume":"48","author":"Kim","year":"2016","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.clgc.2024.102280_bib0032","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrurol.2017.11","article-title":"The evolving genomic landscape of urothelial carcinoma","volume":"14","author":"Glaser","year":"2017","journal-title":"Nat Rev Urol"},{"issue":"6","key":"10.1016\/j.clgc.2024.102280_bib0033","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cell.2019.02.012","article-title":"Characterizing mutational signatures in human cancer cell lines reveals episodic APOBEC mutagenesis","volume":"176","author":"Petljak","year":"2019","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.clgc.2024.102280_bib0034","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.cell.2012.04.024","article-title":"Mutational processes molding the genomes of 21 breast cancers","volume":"149","author":"Nik-Zainal","year":"2012","journal-title":"Cell"},{"issue":"15","key":"10.1016\/j.clgc.2024.102280_bib0035","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJMra0804615","article-title":"DNA damage, aging, and cancer","volume":"361","author":"Hoeijmakers","year":"2009","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.clgc.2024.102280_bib0036","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrc.2015.4","article-title":"DNA repair, genome stability and cancer: a historical perspective","volume":"16","author":"Jeggo","year":"2016","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"10.1016\/j.clgc.2024.102280_bib0037","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9040028","article-title":"DNA repair pathway alterations in bladder cancer","volume":"9","author":"Mouw","year":"2017","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.clgc.2024.102280_bib0038","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3233\/BLC-170129","article-title":"Molecular and clinical insights into the role and significance of mutated DNA repair genes in bladder cancer","volume":"4","author":"Abbosh","year":"2018","journal-title":"Bladder Cancer"},{"issue":"7","key":"10.1016\/j.clgc.2024.102280_bib0039","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.urolonc.2020.01.019","article-title":"Mutation signatures to Pan-Cancer Atlas: investigation of the genomic landscape of muscle-invasive bladder cancer","volume":"40","author":"Cooley","year":"2022","journal-title":"Urol Oncol"},{"issue":"10","key":"10.1016\/j.clgc.2024.102280_bib0040","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1158\/2159-8290.CD-14-0623","article-title":"Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma","volume":"4","author":"Van Allen","year":"2014","journal-title":"Cancer Disc"},{"key":"10.1016\/j.clgc.2024.102280_bib0041","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.808542","article-title":"Association of FLG mutation with tumor mutation load and clinical outcomes in patients with gastric cancer","volume":"13","author":"Yicheng","year":"2022","journal-title":"Front Genet"},{"issue":"6","key":"10.1016\/j.clgc.2024.102280_bib0042","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1007\/s10238-023-01018-z","article-title":"Identification of FAT4 as a positive prognostic biomarker in DLBCL by comprehensive genomic analysis","volume":"23","author":"Lv","year":"2023","journal-title":"Clin Exp Med"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767324002507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767324002507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T12:36:04Z","timestamp":1741696564000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767324002507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1558767324002507"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2024.102280","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive Genetic Profile of Chinese Muscle-Invasive Bladder Cancer Cohort","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2024.102280","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102280"}}